Sanofi Plans Transfer of 20 Mature Medicines and Three Plants to Cheplapharm
Sanofi intends to transfer a portfolio of established medicines and manufacturing sites to Cheplapharm in exchange for a 26.4% equity stake, allowing the French pharmaceutical group to maintain its focus on newer medicines and vaccines. ([Sanofi][8])